Dark

RGC
Regencell Bioscience Holdings Limited
stock NASDAQ

At Close

May 8, 2025 3:59:55 PM EDT

211.02USD+11.069%(+21.03)129,706

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 8, 2025 9:28:30 AM EDT

236.00USD+24.217%(+46.01)4,785

After-hours

May 8, 2025 4:34:30 PM EDT

217.30USD+2.976%(+6.28)139

Overview HistoricalExchangesShortsMore

open chart

Market Cap

2.80B

Headquarters

TN, USA

Industry

Drug Manufacturers-Specialty & Generic

RDI MCS CNK AMC

RGC Stats

Avg. Vol. 10 Day

203,047

Avg. Vol. 30 Day

131,737

Employees

26,000

Market Cap

2,801,084,471

Shares Out.

13,012,866

On/Off Exchange

52%/48%

6 Month Beta

-1.44

1 Year Beta

-1.22

2 Year Beta

-0.95

3 Year Beta

-0.69

52 Week Low

3.03

52 Week High

268.73

SMA50

38.14

SMA200

14.16

1 Week

+251.44%

1 Month

+624.76%

3 Month

+5,663.19%

6 Month

+3,010.62%

1 Year

+3,771.49%

2 Year

+789.12%

5 Year

+1,950.05%

Profile

we are an early-stage bioscience company that focuses on research, development and commercialization of tcm for the treatment of neurocognitive disorders and degeneration, specifically attention deficit hyperactivity disorder ("adhd"), autism spectrum disorder ("asd") in infectious diseases such as covid-19. our goal is to improve the lives of adhd, asd and covid patients, their families and caregivers and become a market leader for the best tcm treatment globally.

RGC Stock Summary

Regencell Bioscience Holdings Limited (NASDAQ:RGC) stock price today is $211.02, and today's volume is 129,706. RGC is up 11.069% today. The 30 day average volume is 131,737. RGC market cap is 2.80B with 13,012,866 shares outstanding.